As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too (opens in new tab)

Covers Opinion: STAT+: Pharma and biotech leaders are destroying their own industry

Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill seeking to apply the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act to investments in Chinese biotechnology.

Read the original article